United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
471.92
+5.52 (1.18%)
At close: Nov 17, 2025, 4:00 PM EST
472.20
+0.28 (0.06%)
After-hours: Nov 17, 2025, 6:49 PM EST
United Therapeutics Market Cap
United Therapeutics has a market cap or net worth of $20.32 billion as of November 17, 2025. Its market cap has increased by 25.94% in one year.
Market Cap
20.32B
Enterprise Value
15.86B
1-Year Change
25.94%
Ranking
Category
Stock Price
$471.92
Market Cap Chart
Since June 17, 1999, United Therapeutics's market cap has increased from $185.60M to $20.32B, an increase of 10,847.88%. That is a compound annual growth rate of 19.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 20.08B | 27.48% |
| Dec 31, 2024 | 15.75B | 52.44% |
| Dec 29, 2023 | 10.33B | -18.47% |
| Dec 30, 2022 | 12.67B | 30.24% |
| Dec 31, 2021 | 9.73B | 44.26% |
| Dec 31, 2020 | 6.75B | 74.53% |
| Dec 31, 2019 | 3.87B | -18.57% |
| Dec 31, 2018 | 4.75B | -25.75% |
| Dec 29, 2017 | 6.39B | 5.09% |
| Dec 30, 2016 | 6.08B | -14.87% |
| Dec 31, 2015 | 7.15B | 16.16% |
| Dec 31, 2014 | 6.15B | 8.32% |
| Dec 31, 2013 | 5.68B | 109.29% |
| Dec 31, 2012 | 2.71B | -1.54% |
| Dec 30, 2011 | 2.76B | -23.40% |
| Dec 31, 2010 | 3.60B | 26.94% |
| Dec 31, 2009 | 2.83B | 95.09% |
| Dec 31, 2008 | 1.45B | -30.01% |
| Dec 31, 2007 | 2.08B | 64.45% |
| Dec 29, 2006 | 1.26B | -20.99% |
| Dec 30, 2005 | 1.60B | 58.72% |
| Dec 31, 2004 | 1.01B | 105.98% |
| Dec 31, 2003 | 488.70M | 39.91% |
| Dec 31, 2002 | 349.30M | 65.94% |
| Dec 31, 2001 | 210.50M | -29.29% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |